Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal swab culture-guided antibiotic prophylaxis for infection prevention after transrectal prostate biopsy
NL-OMON48812Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ciprofloxacin, trimethoprim + sulfamethoxazole, fosfomycin, pivmecillinam and amoxicillin + clavulanate in prostate cancer (PCa) (2 arms), sponsored by Radboud University Medical Center. Started Apr 2018; status: active, not recruiting.
02
Drugs
ciprofloxacintrimethoprim + sulfamethoxazolefosfomycinpivmecillinamamoxicillin + clavulanate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NL-OMON48812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48812.